Beckers A, Stevenaert A, Mashiter K, Hennen G
J Clin Endocrinol Metab. 1985 Sep;61(3):525-8. doi: 10.1210/jcem-61-3-525.
This retrospective study concerns 40 patients with an apparently nonsecretory pituitary adenoma who were operated on during an 11-yr period from 1971 to 1981. Among them, 6 men had elevated serum FSH levels. LH levels were normal in 5 and slightly elevated in 1. Testosterone levels were low in 2 patients and within normal limits in 2 others. Sexual impotency had developed from 6 months to 1 yr before surgery in all patients. Primary hypogonadism could be eliminated on clinical grounds (recent onset of hypogonadism, previous fertility of 5 of the 6, and postoperative improvement). After transsphenoidal adenomectomy, FSH levels returned to normal values in all, and clinical recovery occurred in most patients. Tumor tissue obtained at operation stained positively for the gonadotropins, but was negative for other pituitary hormones in all patients. The most probable explanation for these findings was that the tumors were responsible for the elevated FSH secretion. This explanation is supported by the immunocytochemical identification of gonadotropin-containing cells in the tumors. We conclude that these 6 men from a series of 40 patients who presented with pituitary tumor but no GH, PRL, or ACTH hypersecretion had primary gonadotropinomas.
这项回顾性研究涉及40例在1971年至1981年的11年期间接受手术的明显无分泌功能的垂体腺瘤患者。其中,6名男性血清促卵泡激素(FSH)水平升高。促黄体生成素(LH)水平5例正常,1例轻度升高。2例患者睾酮水平低,另2例在正常范围内。所有患者在手术前6个月至1年出现性功能障碍。根据临床情况(性腺功能减退近期发病、6例中有5例既往有生育能力且术后改善)可排除原发性性腺功能减退。经蝶窦腺瘤切除术后,所有患者的FSH水平均恢复正常,大多数患者临床症状恢复。手术获取的肿瘤组织对促性腺激素染色呈阳性,但所有患者的其他垂体激素染色均为阴性。对这些发现最可能的解释是肿瘤导致FSH分泌升高。肿瘤中含促性腺激素细胞的免疫细胞化学鉴定支持了这一解释。我们得出结论,在这40例患有垂体肿瘤但无生长激素(GH)、催乳素(PRL)或促肾上腺皮质激素(ACTH)分泌过多的患者中,这6名男性患有原发性促性腺激素瘤。